
亚太地区微流体市场预测至 2027 年 - COVID-19 影响和按产品(微流体芯片、微流体传感器、设备、微泵、微针和其他产品)、材料(PDMS、聚合物、玻璃、硅和其他材料)、应用进行的区域分析(体外诊断、制药和生命科学研究、药物发现和其他应用);和国家
No. of Pages: 173 | Report Code: TIPRE00013011 | Category: Life Sciences
No. of Pages: 173 | Report Code: TIPRE00013011 | Category: Life Sciences
微流体涉及少量流体的处理或操纵。它研究了可以通过使用尺寸为微米的微小通道来处理少量流体的各种系统。微流控是一项新兴技术,在生物、化学、光学和信息技术领域有着广泛的应用。该技术广泛应用于毛细管电泳、质谱样品注射、免疫分析、流式细胞术、DNA分析、细胞分离和操作、PCR扩增等各种过程。此外,微流控还用于癌症等疾病的诊断和研究。
亚太地区微流体市场预计将从 2019 年的 22.9422 亿美元增至 2027 年的 87.8824 亿美元。预计从 2020 年开始,该市场将以 18.6% 的复合年增长率增长到2027年。推动市场增长的因素包括微流控技术在即时测试中的应用以及微流控产品的技术发展。然而,新兴经济体采用率较低是阻碍市场增长的主要因素。新冠肺炎疫情影响了亚太地区国家,导致冠状病毒病例死亡率很高。研究机构正在开发基于微流控技术的COVI19检测装置。
从产品来看,2019年设备细分市场占据最大份额;然而,预计微流控芯片领域在预测期内将达到市场上最高的复合年增长率。就材料而言,PDMS 细分市场在 2019 年占据了更大的市场份额,预计类似细分市场在预测期内将获得更高的市场份额。同样,在应用方面,体外诊断领域在 2019 年占据了更大的市场份额,预计在预测期内市场复合年增长率将更高。
世界健康组织(WHO)、世界心脏联合会、国家生物技术信息中心是报告中包含的亚太微流体市场的一些主要主要和次要来源。
微流体市场 –按产品
微流体市场 -按材质
微流体市场——按应用划分
Strategic insights for Asia Pacific Microfluidics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 2,294.22 Million |
Market Size by 2027 | US$ 8,788.24 Million |
Global CAGR (2020 - 2027) | 18.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Microfluidics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Microfluidics Market is valued at US$ 2,294.22 Million in 2019, it is projected to reach US$ 8,788.24 Million by 2027.
As per our report Asia Pacific Microfluidics Market, the market size is valued at US$ 2,294.22 Million in 2019, projecting it to reach US$ 8,788.24 Million by 2027. This translates to a CAGR of approximately 18.6% during the forecast period.
The Asia Pacific Microfluidics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Microfluidics Market report:
The Asia Pacific Microfluidics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Microfluidics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Microfluidics Market value chain can benefit from the information contained in a comprehensive market report.